ATTACHMENT 7 = 510(k) SUMMARY (
510(k) Summary
General Information
Classification Class Il
JAN 26 2007
Trade Name AtriCure Ablation System
Manufacturer AtriCure, Inc.
6033 Schumacher Park Drive
West Chester, OH 45069
Contact Elsa Abruzzo
Vice President, Clinical and Regulatory Affairs .
Intended Use .
The AtriCure Ablation System is intended to ablate soft tissues during
general surgery using radiofrequency energy.
Predicate Devices
The predicate devices for the AtriCure Ablation System are the AtriCure
Bipolar System (K020919), the AtriCure Transpolar™ System (K052893),
and the Medtronic Cardioablate Surgical Ablation System (K060400)
Device Description
The AtriCure Ablation System includes a hand held, single use, bipolar
radiofrequency (RF) surgical instrument (Isolator® Transpolar Clamps or
Isolator Synergy™ Clamps) intended for the ablation of soft tissues and an
accessory instrument guide (Glidepath™ Tape). The clamp handpieces
are connected via an integral cable to the AtriCure re-useable Ablation and
Sensing Unit (ASU2) or an Isolator Switch Matrix (ASB3) console.
Materials
All materials in the AtriCure Ablation System are suitable for their intended
use and have been used in numerous previously cleared products.
Testing was conducted in Accordance with ISO 10993-1 to ensure
appropriate biocompatibility of all materials.
Testing
Appropriate product testing was conducted to evaluate conformance to
product specification and substantial equivalence to predicate devices.
Summary of Substantial Equivalence
The AtriCure Ablation System is equivalent to the predicate products. The
indications for use, basic overall function, and materials used are
substantially equivalent.
AtriCure AtriCure Ablation System with Synergy Clamp 510(k)
10/31/2006

2 g DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
"nae Food and Drug Administration
. 9200 Corporate Boulevard
Rockville MD 20850

Regulatory Technology Services, LLC
% Mr. Mark Job
Responsible Third Party Official
1394 25" Street, NW
Buffalo, Minnesota 55313
Re: K063630

Trade/Device Name: Atricure Ablation System

Regulation Number: 21 CFR 878.4400

Regulation Name: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: Class Il

Product Code: GEI

Dated: December 4, 2006

Received: December 6, 2006
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class If (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. Mark Job :
This letter will allow you to begin marketing your device as described in your Section 310(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115 Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www. fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

jf ark N. Melkerson

Director

Division of General, Restorative

and Neurological Devices

Office of Device Evaluation

Center for Devices and

Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): IC 0616380
Device Name: AtriCure Ablation System
Indications For Use:
The AtriCure Ablation System is intended to ablate soft tissues during
general surgery using radiofrequency energy.
Prescription Use Vv AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
sien a ~
vision of General, Restorative
sad Neurological Devices
Page 1 of 1
Mk) Number__K 06763 oO 9
AtriCure AtriCure Ablation System with Synergy Clamp 510(k)
10/31/2006

